Skip to content
Research Article Open access CC BY 4.0

Aripiprazole Induced Hypersexuality in A 42-Year-Old Woman with Bipolar Disorder: A Rare Case Report

Hafiz Olatunde, Tajudeen Basiru, Odiaka Mark Anombem, Adeniyi Kayode Busari, Gibson Anugwom, Sochima Ochije, Salisu Aikoye

Journal of Advances in Medicine and Medical Research · pp. 218–221 · Published 31 Aug 2023

10.9734/jammr/2023/v35i205192

Abstract

Background: Aripiprazole use is associated with a very rare side effect of hypersexuality, which was experienced by the patient described in this case study. Hypersexuality can be a very distressing symptom and may also hinder medication compliance. Case Presentation: A 42-year-old woman with bipolar II disorder developed hypersexuality three weeks after starting aripiprazole, which was used in the treatment of her bipolar disorder. Discussion: Aripiprazole works by reducing dopaminergic neurotransmission in the mesolimbic pathway. It is believed that due to aripiprazole’s agonistic dopaminergic action in the mesolimbic circuit, it can increase sexual desire. Conclusion: This case report emphasizes the importance of closely monitoring patients taking aripiprazole for hypersexuality and adds to the existing body of knowledge of aripiprazole-induced hypersexuality.

Aripiprazole bipolar disorder hypersexuality

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.